Intratumoral Ral-binding protein 1 (RalBP1) expression as a potential predictor of bevacizumab treatment efficacy in patients with ovarian cancer. This is an ASCO Meeting Abstract from the 2024 ASCO ...
Biomarkers for immunotherapy: Results from the analysis of an HLA-status double-blind, biologically randomized phase II study of five therapeutic epitope-peptides with oxaliplatin-based chemotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results